UM

浏览/检索结果: 共22条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation Journal article
FRONTIERS IN PHARMACOLOGY, 2019,Volume: 10
作者:  Zihao Wang;  Ke-Gang Linghu;  Yuanjia Hu;  Huali Zuo;  Hao Yi;  Shi-Hang Xiong;  Jinjian Lu;  Ging Chan;  Hua Yu;  Run-Yue Huang
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
Rheumatoid Arthritis  Network Pharmacology  Traditional Chinese Medicine  Huayu-qiangshen-tongbi Formula  In Vitro Validation  
Novel Compound-Target Interactions Prediction for the Herbal Formula Hua-Yu-Qiang-Shen-Tong-Bi-Fang Journal article
CHEMICAL & PHARMACEUTICAL BULLETIN, 2019,Volume: 67,Issue: 8,Page: 778-785
作者:  Zihao Wang;  Hui-Heng Lin;  Kegang Linghu;  Run-Yue Huang;  Guangyao Li;  Huali Zuo;  Hua Yu;  Ging Chan;  Yuanjia Hu
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/06
Herbal Formula  Hua-yu-qiang-shen-tong-bi-fang  Natural Product  In-silico Target Identification  Network Link Prediction  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
作者:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
收藏  |  浏览/下载:2/0  |  提交时间:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 1,Page: 69-80
作者:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin;  Hu, Yuanjia
收藏  |  浏览/下载:17/0  |  提交时间:2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
Progress of Studies on Traditional Chinese Medicine Based on Complex Network Analysis Journal article
Wordl Journal of Traditional Chinese Medicine, 2017,Volume: 3,Issue: 3,Page: 28-37
作者:  Qian‑Ru Zhang;  Xiang‑Jun Kong;  Hai‑Yu Xu;  Yi‑Tao Wang;  Yuan‑Jia Hu
收藏  |  浏览/下载:0/0  |  提交时间:2019/01/10
Complex Network Analysis  Formula  Mechanism  Syndrome  Traditional Chinese Medicine  
Synergistic effects of Chuanxiong-Chishao herb-pair on promoting angiogenesis at network pharmacological and pharmacodynamic levels Journal article
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2017,Volume: 23,Issue: 9,Page: 654-662
作者:  Wang Yan;  Guo Gang;  Yang Bin-rui;  Xin Qi-qi;  Liao Qi-wen;  Lee Simon Ming-Yuen;  Hu Yuan-jia;  Chen Ke-jj;  Cong Wei-hong
收藏  |  浏览/下载:17/0  |  提交时间:2018/10/30
Tetramethylpyrazine  Paeoniflorin  Angiogenesis  Network Pharmacology  
Obstacles and opportunities in Chinese pharmaceutical innovation Journal article
Globalization and Health, 2017,Volume: 13,Issue: 1,Page: 21
作者:  Ni J.;  Zhao J.;  Ung C.O.L.;  Hu Y.;  Hu H.;  Wang Y.
收藏  |  浏览/下载:10/0  |  提交时间:2018/11/06
China  Global Network  Innovation  Obstacles  Opportunities  Pharmaceutical Industry  
The best strategy for HCC patients at each BCLC stage: a network meta-analysis of observational studies Journal article
ONCOTARGET, 2017,Volume: 8,Issue: 12,Page: 20418-20427
作者:  Chang, Lei;  Wang, Yitao;  Zhang, Jibo;  Guo, Tao
收藏  |  浏览/下载:2/0  |  提交时间:2018/11/01
hepatocellular carcinoma  BCLC stages  network meta-analysis  
Pharmaceutical innovation network: Global patterns and the role of China Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 259-281
作者:  Pengpeng Li;  Huiheng Lin;  Yuanjia Hu
收藏  |  浏览/下载:10/0  |  提交时间:2019/01/15
Pharmaceutical Innovation  Drug Patents  Network Analysis  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
作者:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
收藏  |  浏览/下载:10/0  |  提交时间:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation